{
  "chunk_id": "V_iii_8_A_16",
  "content": "/>\nV.iii.8.A.2.c\n.\nMalignant Neoplasms of the Gynecological System\nSeparate 100-percent evaluations will be assigned for both active gynecological cancer and active breast cancer.  Metastasis of a gynecological cancer or breast cancer to a different body system will also be evaluated separately.\nConsider corresponding entitlement to SMC.\nReferences\n:  For more information on\ntemporary total evaluations for cancers, see\nM21-1, Part VIII, Subpart iv, 8.D.3.e\nevaluating malignant neoplasms and associated impairments, see\nM21-1, Part V, Subpart ii, 3.D.5.a and b\n, and\nentitlement to SMC (k) for anatomical loss of a creative organ, see\n38 CFR 3.350(a)\n, and\nM21-1, Part VIII, Subpart iv, 4.A.4.d\n.",
  "title": "M21-1, Part V, Subpart iii, Chapter 8, Section A - Disabilities of the Gynecological System",
  "citation": "Part V, Subpart iii, Chapter 8, Section A",
  "source_url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180511/M21-1-Part-V-Subpart-iii-Chapter-8-Section-A-Disabilities-of-the-Gynecological-System",
  "updated": "",
  "scraped_at": "2025-06-16T22:45:16.761925",
  "tags": [
    "m21-1"
  ]
}